ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

How Gene Editing is Changing Otolaryngology

by Nikki Kean • December 6, 2017

  • Tweet
  • Email
Print-Friendly Version
© Natali_ Mis / shutterstock.com

© Natali_ Mis / shutterstock.com

Many factors come into play to cause hearing loss. In childhood, almost 50% of cases can be traced to the patient’s genes. Genetic testing promises to help identify such hearing loss before it has progressed, or potentially even before birth, while also helping to steer treatment—most notably, by identifying candidates for a new groundbreaking gene-editing strategy that selectively removes defective genes and eliminates the risk of inheriting the trait for future generations.

You Might Also Like

  • Otolaryngology Research Increasingly Supports Genetic Screening to Evaluate Pediatric Hearing Loss
  • Gene Therapy: A Promising Role in Otolaryngology
  • Cochlear Implants: Changing Indications and New Technology
  • First Two Patients Respond to Gene Therapy in Melanoma Study
Explore This Issue
December 2017

To explore the current status of gene editing in the field of otolaryngology, ENTtoday spoke with a number of leading researchers in the field.

Genes Involved in Hearing Loss

Researchers have identified 46 known genes involved in non-syndromic hearing loss, and expect to discover more. The most frequent genes implicated in recessive non-syndromic hearing loss are GJB2 (connexin 26 gene), which is responsible for more than half of cases, followed by SLC26A4, MYO15A, OTOF, CDH23 and TMC1 (Mutat Res. 2009;681[2-3]:189-196).

Although the majority of hereditary hearing loss is non-syndromic, many genetic syndromes also cause deafness, including neurofibromatosis type 2 and Usher syndrome. In addition, age-related hearing loss is thought to have a genetic component (SNPs rs4932196 and rs58389158), although the exact genetic cause(s) of the disease is still being elucidated (PLoS Genet. 2016;12:e1006371).

The discovery of genetic mutations has come with a whole host of potential genetic therapies; however, “the dominant deafness genes cannot be corrected with gene replacement strategies, so researchers are turning to gene-editing approaches to correct those types of hearing losses: either silencing RNA (siRNA) or CRISPR strategies,” said Hinrich Staecker, MD, PhD, the David and Mary Zamierowsky Professor of otolaryngology at the University of Kansas School of Medicine in Kansas City.

CRISPR, which stands for clustered regularly interspaced short palindromic repeats, uses the Cas9 enzyme to cut a specific target sequence on a mutant gene—cutting both strands of the DNA. Repair enzymes can then be inserted to repair and seal the cut with new genetic information, permanently changing the underlying genetic code. A landmark study in Nature reported the results of using CRISPR-Cas9 to correct a mutation in a gene that causes hypertrophic cardiomyopathy in human embryos (Nature. 2017;548:13–14). Researchers have questioned the findings of that study, however (see “Landmark Gene-Editing Study Called into Question,”).

The Promise of Gene Editing

“Gene editing is now much simpler and better than it has ever been. Even though we have tried to edit genes for a long time, the relatively recent discovery of the CRISPR-Cas technology, in which we can discreetly edit parts of the gene, is very exciting,” said D. Bradley Welling, MD, PhD, the Walter Augustus LeCompte Professor and chair of the department of otolaryngology at Harvard Medical School in Boston, and editor of ENTtoday’s sister publication Laryngoscope Investigative Otolaryngology.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Departments, Home Slider, Special Reports Tagged With: clinical best practices, gene editing, gene replacement, gene replacement for hearing loss, hearing lossIssue: December 2017

You Might Also Like:

  • Otolaryngology Research Increasingly Supports Genetic Screening to Evaluate Pediatric Hearing Loss
  • Gene Therapy: A Promising Role in Otolaryngology
  • Cochlear Implants: Changing Indications and New Technology
  • First Two Patients Respond to Gene Therapy in Melanoma Study

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.